Mold-Tek Packaging reported robust Q4 FY25 revenue growth driven by strong Food & FMCG performance and a significant ramp-up in its new Pharma division, which achieved breakeven. While full-year PAT saw a dip due to higher costs, the outlook for FY26 focuses on continued pharma expansion and a recovery in the paints segment.
E2E Networks reported robust YoY growth for FY25, with revenue up 74% and PAT up 117%. Q4FY25 saw a strategic QoQ revenue dip to ₹335 Mn as the company focused on large-scale trials, but PAT improved QoQ to ₹136 Mn, aided by higher other income. Significant GPU capacity expansion and the L&T partnership are key to its future AI and sovereign cloud strategy, with an ambitious MRR target of ₹35-40 crores by March 2026.